Abstract A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become
a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …

Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with
increased in-hospital mortality and worse clinical evolution, raising concerns towards …

With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …

Background and aims Morbidity and mortality from coronavirus disease 2019 (COVID-19) is
higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease …

COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …

The world is currently facing a frightening coronavirus disease-2019 (COVID-19) epidemic.
Severity of COVID-19 presentation is highly variable among infected individuals with …

Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has prompted the scientific
community to explore potential treatments or vaccines against severe acute respiratory …

Rationale Hypertension, obesity and diabetes are major risk factors associated with
morbidities underlying COVID-19 infections. Regression analysis correlated presence of …

The article describes the rationale for inhibition of the renin-angiotensin system (RAS)
pathways as specific targets in patients infected by SARS-CoV-2 in order to prevent positive …

The severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2), a novel coronavirus
responsible for the recent infectious pandemic, is known to downregulate angiotensin …